Journal of Medical Virology

Papers
(The H4-Index of Journal of Medical Virology is 59. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Comparison of the pediatric hospitalizations due to COVID‐19 and H1N1pdm09 virus infections during the pandemic period714
The potential rationale of COVID‐19 vaccine‐induced myopericarditis491
Comparative analyses of small molecule and antibody inhibition on glycoprotein‐mediated entry of Měnglà virus with other filoviruses465
Change in willingness to COVID‐19 vaccination in China: Two online surveys during the pandemic411
Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries258
Seroprevalence of neutralizing antibodies against the respiratory syncytial virus in healthy adults in Guangzhou, southern China246
218
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protection205
Effects of baloxavir and oseltamivir antiviral therapy on the transmission of seasonal influenza in China: A mathematical modeling analysis204
Dynamics of spreading of SARS‐CoV‐2 in a Belgian hemodialysis facility: The importance of the analysis of viral strains193
Public screening for COVID‐19 in Wuhan, China and beware of the antibody positive in women and tumor patients178
Prisoners of variants, or free to act as prisoners of swabs? The case of Italy177
Prolonged fecal shedding of SARS‐CoV‐2 in a young immunocompetent COVID‐19 patient: A case report and literature overview165
Issue Information155
153
Issue Information132
Melatonin use for SARS‐CoV‐2 infection: Time to diversify the treatment portfolio129
Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India129
Booster vaccination strategy: Necessity, immunization objectives, immunization strategy, and safety120
Comparison of demographic and clinical characteristics of hospitalized COVID‐19 patients with severe/critical illness in the first wave versus the second wave120
Preparation of highly specific monoclonal antibodies against SARS‐CoV‐2 nucleocapsid protein and the preliminary development of antigen detection test strips111
Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID‐19110
An exploratory study on the propagation of SARS‐CoV‐2 variants: Omicron is the most predominant variant109
Highly sensitive and rapid detection of SARS‐CoV‐2 via a portable CRISPR‐Cas13a‐based lateral flow assay107
Impact of hepatitis B surface antigen positive grafts on liver transplantation in patients with benign and malignant liver disease106
Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples100
Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark95
Advances in laboratory detection methods and technology application of SARS‐CoV‐291
Examination of control asymptomatic cohorts reveals heightened anti‐EBV and HHV‐6 A/B dUTPase antibodies in the aging populations89
Ramsay Hunt syndrome and concurrent varicella‐zoster virus meningitis in Denmark: A nationwide cohort study89
Exploring the dynamics of the 2022 mpox outbreak in Canada88
Cytomegalovirus‐RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof‐of‐Concept Study87
Posttranslational modifications of ACE2 protein: Implications for SARS‐CoV‐2 infection and beyond87
Real‐world effectiveness of sotrovimab and remdesivir for early treatment of high‐risk hospitalized COVID‐19 patients: A propensity score adjusted retrospective cohort study85
Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting85
Inhibiting cardiac autophagy suppresses Zika virus replication78
Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 202278
Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg‐positive chronic hepatitis B78
Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity78
Significant neutralizing escapes of Omicron and its sublineages in SARS‐CoV‐2‐infected individuals vaccinated with inactivated vaccines77
Outcomes of definitive local therapy with intensity‐modulated radiation therapy in elderly patients ≥70 years with HPV‐associated oropharyngeal cancer76
Cytological features of human papillomavirus‐infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 275
Association between cytomegalovirus seropositivity and all‐cause mortality: An original cohort study70
Advanced technologies towards improved HPV diagnostics69
Azvudine and nirmatrelvir–ritonavir in hospitalized patients with moderate‐to‐severe COVID‐19: Emulation of a randomized target trial67
Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg‐Negative Stage of Chronic Hepatitis B67
On coming back, the scaring COVID‐19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS‐CoV2 spreading67
Monkeypox Virus Subverts the Inflammatory Response of Macrophages at the Maternal‐Fetal Interface66
No signs of “tripledemic” in Finnish children65
Detection of SARS‐CoV‐2 virus in middle ear effusions and its association with otitis media with effusion64
Influenza vaccination on SARS‐CoV‐2 infection risk: A subgroup analysis on geographic factor64
ZNFX1 antisense RNA1 promotes antiviral innate immune responses via modulating ZNFX1 function64
Novel diarylpyrimidine subtypes as HIV‐1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile63
Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study63
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV62
Corrigendum61
Repurposing of the antibiotic nitroxoline for the treatment of mpox61
Diversity of picornaviruses detected in diarrheal samples from children in Belém, Brazilian Amazon (1982–2019)60
Epidemiological Characteristics of Neuro‐Specific Antibodies Following Viral Infections59
Cytomegalovirus seropositivity and its correlation with all‐cause mortality among US adults59
Epidemiological characteristics of norovirus infection in pediatric patients during the COVID‐19 pandemic59
0.13804602622986